Diagnosis

Myoma uteri

Benign monoclonal tumors originating from smooth muscle cells within the uterus in women of reproductive age.

Also known as: Fibroid, Leiomyoma uteri, Myoma, Uterine fibroids

Etiology

Cause [wtq]

Pathophysiology [sb3][wtq]

  1. Estrogen and progestogen sensitive uterine leiomyoma (usually asymptomatic)

  2. Compression of nearby structures

  3. Faster growth than its blood supply can support it --> hemorrhagic infarction

  4. Clinical manifestation (25-30%)

    • Pelvic and low back pain/pressure

    • Abnormal uterine bleeding

    • Anemia

    • Bladder or bowel dysfunction

Risk factors [kzw]

Complications [wtq]

Epidemiology

Prevalence per 100.000 [s9b][pou][sb3][kzw][hu9][pav][dcs]

Epidemiology chart for Prevalence

Incidence per 100.000 [s9b][pou][sb3][kzw][hu9][pav][dcs]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Dyschezia, Dyspareunia, Infertility, Menorrhagia, Metrorrhagia, Polyuria, Vaginal bleeding

Clinical findings

Elevated Lactate, Urinary retention

Anamneses

None listed.

Localized findings

Pain
Radiates
Regio hypogastricaLumbarSacral
Onset
Subacute (hours)Gradual (days)
Pattern
Constant
Provoked by
CoitusDefecationMenstruation
Quality
Cramping
Severity
Mild (1-3)Moderate (4-7)

Approach

Treatment

  1. Surveillance if asymptomatic myoma uteri [wtq]

    • Repeat imaging if change in clinical symptoms (bleeding, pain, anemia, or urinary or bowel dysfunction)

    • Pain: NSAIDs

    • Menorrhagia: Tranexamic acid

  2. Medical therapy: suppress the hypothalamic-pituitary-ovarian axis

    • Oral contraceptives

    • Progestins

    • Levonorgestrel-releasing intrauterine system

    • GnRH-agonists

    • Aromatase inhibitors

  3. Surgical intervention:

    • Myomectomy

    • Endometrial ablation

    • Hysterectomy

  4. Uterine artery embolization

  5. Radiofrequency ablation

Differential diagnoses

Adenomyosis, Braxton Hicks contraction, Endometrial cancer, Leiomyosarcoma, Lipoleiomyoma, Pregnancy


References

[1] Barjon K, Kahn J, Singh M. Uterine Leiomyomata. [Updated 2025 May 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK546680/

[2] Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health. 2012 Mar 26;12:6

[3] Sidło-Stawowy, A., Nowak, K., Nowak, S., Drosdzol-Cop, A., Skrzypulec-Plinta, V., & Janik, A. (2015). Mięśniaki macicy - metody leczenia. Ginekologia i Położnictwo -medical project, R.10, Article 3.

[4] Victory R, Romano W, Bennett J, Diamond MP. Uterine leiomyomas: epidemiology, diagnosis, and management. In: Bieber EJ, Sanfilippo JS, Horowitz IR, Shafi MI, eds. Clinical Gynecology. Cambridge University Press; 2015:223-252

[5] Wegienka G, Havstad S, Coleman C, Cooper T, Wesselink A, Upson K, Marsh EE, Vines AI, Harmon Q, Baird D, Wise LA. Ultrasound-Confirmed, Age-Specific Uterine Leiomyoma Incidence in a Cohort of Black Individuals. Obstet Gynecol. 2022 Dec 1;140(6):1042-1048

[6] Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003 Jan;188(1):100-7

[7] Matasariu DR, Ursache A, Himiniuc L, Toma B, Boiculese VL, Grigore M, Dumitrascu I. Research on myoma in Northeastern Romania and socio-medical outcomes. Exp Ther Med. 2022 Jan;23(1):30

[8] Odokuma, E. I. 2014. “Age Prevalence of Leiomyoma Uteri; A Histopathologic Study”. Current Journal of Applied Science and Technology 4 (16):2395-99

[9] http://emedicine.medscape.com/article/1611373 (2014-01-02); [Medscape]

Scroll to top